Update on carbohydrate-containing antibacterial agents (Q38089193)

28 August 2017

title

Update on carbohydrate-containing antibacterial agents (English)

1 reference

28 August 2017

Georg Schitter

1

1 reference

28 August 2017

Tanja M Wrodnigg

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

Expert Opinion on Drug Discovery

28 August 2017

published in

1 reference

28 August 2017

volume

4

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

315-356

1 reference

Combating resistance in a challenging, changing environment

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Bacterial resistance: a sensitive issue complexity of the challenge and containment strategy in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Bacterial resistance to antibiotics: modified target sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Carbohydrate-Based Antibiotics: A New Approach to Tackling the Problem of Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Syntheses around the transglycosylation step in peptidoglycan biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Glycopeptide and lipoglycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Glycopeptides: Update on an old successful antibiotic class

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

The structure and mode of action of glycopeptide antibiotics of the vancomycin group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Structure, biochemistry and mechanism of action of glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Registered and Investigational Drugs for the Treatment of Methicillin-Resistant Staphylococcus aureus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Vancomycin: does it still have a role as an antistaphylococcal agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Vancomycin resistance in gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Vancomycin assembly: nature's way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Limitations of vancomycin in the management of resistant staphylococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Update on glycopeptide use in german university hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

The Vancomycin Group of Antibiotics and the Fight against Resistant Bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Vancomycin analogues containing monosaccharides exhibit improved antibiotic activity: a combined one-pot enzymatic glycosylation and chemical diversification strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Combinatorial glycosylation of glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Treatment options for multidrug-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Glycopeptides in clinical development: pharmacological profile and clinical perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Solid- and solution-phase synthesis of vancomycin and vancomycin analogues with activity against vancomycin-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Oritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Oritavancin--an investigational glycopeptide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Oritavancin: a new avenue for resistant Gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Mechanism of action of oritavancin and related glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Telavancin: a novel lipoglycopeptide antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Telavancin: a novel lipoglycopeptide for serious gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

In vitro activity of telavancin against resistant gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Review of dalbavancin, a novel semisynthetic lipoglycopeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Dalbavancin, a long-acting lipoglycopeptide for the treatment of multidrug-resistant Gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Dalbavancin: a novel antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

The mechanism of action of ramoplanin and enduracidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Biosynthetic pathway for mannopeptimycins, lipoglycopeptide antibiotics active against drug-resistant gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Hydrophobic acetal and ketal derivatives of mannopeptimycin-alpha and desmethylhexahydromannopeptimycin-alpha: semisynthetic glycopeptides with potent activity against Gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Configurational entropy and cooperativity between ligand binding and dimerization in glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Aminoglycoside antibiotics: old drugs and new therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Molecular understanding of aminoglycoside action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

2-Deoxystreptamine: central scaffold of aminoglycoside antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Structural insights into translational fidelity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Comparison of X-ray crystal structure of the 30S subunit-antibiotic complex with NMR structure of decoding site oligonucleotide-paromomycin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Molecular insights into aminoglycoside action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Structural basis for aminoglycoside inhibition of bacterial ribosome recycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Molecular recognition of aminoglycoside antibiotics by ribosomal RNA and resistance enzymes: an analysis of x-ray crystal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Modifications of aminoglycoside antibiotics targeting RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Novel acyclic deoxystreptamine mimetics targeting the ribosomal decoding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Rational design of azepane-glycoside antibiotics targeting the bacterial ribosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Dimeric aminoglycosides as antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Cellular Uptake of Aminoglycosides, Guanidinoglycosides, and Poly-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Studies on the mechanism of inhibition of bacterial ribonuclease P by aminoglycoside derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Effect of varying the 4''-position of arbekacin derivatives on antibacterial activity against MRSA and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Aminoglycoside antibiotic derivatives: preparation and evaluation of toxicity on cochlea and vestibular tissues and antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Structure-based design, synthesis, and A-site rRNA cocrystal complexes of functionally novel aminoglycoside antibiotics: C2" ether analogues of paromomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

New insights into aminoglycoside antibiotics and derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Exploring the use of conformationally locked aminoglycosides as a new strategy to overcome bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Defining the molecular forces that determine the impact of neomycin on bacterial protein synthesis: importance of the 2'-amino functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Conformational constraint as a means for understanding RNA-aminoglycoside specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Production of aminoglycosides in non-aminoglycoside producing Streptomyces lividans TK24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Biosynthesis of spectinomycin: heterologous production of spectinomycin and spectinamine in an aminoglycoside-deficient host, Streptomyces venezuelae YJ003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

The gene cluster for spectinomycin biosynthesis and the aminoglycoside-resistance function of spcM in Streptomyces spectabilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Biosynthesis of aminocyclitol-aminoglycoside antibiotics and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

A journey across the sequential development of macrolides and ketolides related to erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Design and synthesis via click chemistry of 8,9-anhydroerythromycin A 6,9-hemiketal analogues with anti-MRSA and -VRE activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Structural basis for the antibiotic activity of ketolides and azalides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

23S rRNA 2058A-->G alteration mediates ketolide resistance in combination with deletion in L22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: length optimization and zero carbon linker oximes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Azalides from azithromycin to new azalide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Initiation of transcription in vitro is inhibited by lipiarmycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

A new insight into solid-state conformation of macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Challenges in antimicrobial drug discovery and the potential of nucleoside antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

MraY Inhibitors as Novel Antibacterial Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Biosynthesis of the tunicamycins: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Conformational analysis of chirally deuterated tunicamycin as an active site probe of UDP-N-acetylhexosamine:polyprenol-P N-acetylhexosamine-1-P translocases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

In vitro antimycobacterial activities of capuramycin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis of caprazamycin analogues and their structure--activity relationship for antibacterial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis of sub-micromolar inhibitors of MraY by exploring the region originally occupied by the diazepanone ring in the liposidomycin structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Caprazamycins, novel lipo-nucleoside antibiotics, from Streptomyces sp. II. Structure elucidation of caprazamycins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Design and synthesis of diketopiperazine and acyclic analogs related to the caprazamycins and liposidomycins as potential antibacterial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Selective inhibition of the bacterial translocase reaction in peptidoglycan synthesis by mureidomycins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Solid-phase synthesis and biological evaluation of a uridinyl branched peptide urea library

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Solid-phase synthesis of a thymidinyl dipeptide urea library

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Structures of the muraymycins, novel peptidoglycan biosynthesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Muraymycins, novel peptidoglycan biosynthesis inhibitors: synthesis and SAR of their analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Sansanmycins B and C, new components of sansanmycins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis and biological evaluation of bicyclic nucleosides as inhibitors of M. tuberculosis thymidylate kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Design, synthesis, and biological evaluation of beta-ketosulfonamide adenylation inhibitors as potential antitubercular agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis and antimicrobial activity of some novel nucleoside analogues of adenosine and 1,3-dideazaadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Structure and inhibition of a quorum sensing target from Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis and inhibitory activity of 8-substituted 2-deoxy-beta-KDO against CMP-KDO synthetase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synergistic effect of CMP/KDO synthase inhibitors with antimicrobial agents on inhibition of production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157:H7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Agonistic and antagonistic properties of a Rhizobium sin-1 lipid A modified by an ether-linked lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Exploration of specificity in germline monoclonal antibody recognition of a range of natural and synthetic epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis of spacer-containing chlamydial disaccharides as analogues of the alpha-Kdop-(2-->8)-alpha-Kdop-(2-->4)-alpha-Kdop trisaccharide epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Catalytic mechanism and molecular recognition of E. coli UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase probed by mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

DFT investigation on the mechanism of the deacetylation reaction catalyzed by LpxC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Kinetic analysis of the zinc-dependent deacetylase in the lipid A biosynthetic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Structure of the LpxC deacetylase with a bound substrate-analog inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Refined solution structure of the LpxC-TU-514 complex and pKa analysis of an active site histidine: insights into the mechanism and inhibitor design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

A structural perspective on the enzymes that convert dTDP-d-glucose into dTDP-l-rhamnose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Crystal structure of glycoside hydrolase family 78 alpha-L-Rhamnosidase from Bacillus sp. GL1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Glycomimetic inhibitors of mycobacterial glycosyltransferases: targeting the TB cell wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Alpha-rhamnosidase inhibitory activities of polyhydroxylated pyrrolidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Syntheses of tetrahydroxyazepanes from chiro-inositols and their evaluation as glycosidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Intermediate release by ADP-L-glycero-D-manno-heptose 6-epimerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

The ATP-binding site of type II topoisomerases as a target for antibacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

The biosynthetic gene clusters of aminocoumarin antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Combinatorial biosynthesis, metabolic engineering and mutasynthesis for the generation of new aminocoumarin antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Biological activities of novel gyrase inhibitors of the aminocoumarin class

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis and antituberculosis activity of C-phosphonate analogues of decaprenolphosphoarabinose, a key intermediate in the biosynthesis of mycobacterial arabinogalactan and lipoarabinomannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis of symmetrical C- and pseudo-symmetrical O-linked disaccharide analogs for arabinosyltransferase inhibitory activity in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

A Madagascar Sponge Batzella sp. as a source of alkylated iminosugars

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Glycolipids from the red alga Chondria armata (Kutz.) Okamura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Neocitreamicins I and II, novel antibiotics with activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Genomic analyses lead to novel secondary metabolites. Part 3. ECO-0501, a novel antibacterial of a new class.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Novel antibacterial azetidine lincosamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

N-D-aldopentofuranosyl-N'-[p-(isoamyloxy)phenyl]-thiourea derivatives: potential anti-TB therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Domain requirement of moenomycin binding to bifunctional transglycosylases and development of high-throughput discovery of antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Genes encoding enzymes responsible for biosynthesis of L-lyxose and attachment of eurekanate during avilamycin biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Glycomimetics and glycodendrimers as high affinity microbial anti-adhesins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Intervention with bacterial adhesion by multivalent carbohydrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Glycodendrimers as anti-adhesion drugs against type 1 fimbriated E. coli uropathogenic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Iterative synthesis of spacered glycodendrons as oligomannoside mimetics and evaluation of their antiadhesive properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis of multivalent Streptococcus suis adhesion inhibitors by enzymatic cleavage of polygalacturonic acid and 'click' conjugation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

How to fight antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Unusual sugar biosynthesis and natural product glycodiversification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis of solid-supported mirror-image sugars: a novel method for selecting receptors for cellular-surface carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Synthesis of the naringinase inhibitors l-swainsonine and related 6-C-methyl-l-swainsonine analogues: (6R)-C-methyl-l-swainsonine is a more potent inhibitor of l-rhamnosidase by an order of magnitude than l-swainsonine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

Arabinofuranose disaccharide analogs as inhibitors of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17460440902778725

A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.37.309

Identifiers

DOI

10.1517/17460440902778725

1 reference

28 August 2017

1 reference